NCT00736632View on ClinicalTrials.gov

Vitamin D, Insulin Resistance, and Cardiovascular Disease

NACompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

January 13, 2019

Study Completion Date

January 13, 2019

Conditions
Vitamin D DeficiencyInsulin ResistanceType 2 Diabetes MellitusCardiovascular DiseaseHypertension
Interventions
DRUG

Vitamin D3

Cholecalciferol 4000 units orally daily Calcium carbonate 500 mg orally twice daily

DRUG

Placebo

Placebo pill orally daily Calcium carbonate 500 mg twice daily

Trial Locations (1)

63110

Washington Universiy, St Louis

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

American Diabetes Association

OTHER

lead

Washington University School of Medicine

OTHER

NCT00736632 - Vitamin D, Insulin Resistance, and Cardiovascular Disease | Biotech Hunter | Biotech Hunter